ABSTRACT
C
ongenital diaphragmatic hernia (CDH), with an incidence of 1 case per 2000 live births, is an anomaly associated with substantial morbidity and mortality. 1 Survivors of CDH are at risk for long-term respiratory, gastrointestinal, nutritional, hearing, and neurologic sequelae, requiring multidisciplinary support, especially during early childhood. 1 Prenatal predictive factors for increased morbidity and mortality include prenatal imaging findings of liver herniation into the chest, lung to head ratio on prenatal sonography, or lung volumes on fetal MR imaging. [2] [3] [4] The size of the diaphragmatic defect is another factor that likely plays a major role in morbidity and mortality in infants with congenital diaphragmatic hernia. 5 However, the association of the defect size with evidence of injury on brain imaging has not been studied, to our knowledge. Long-term neurodevelopmental and neurobehavioral disabilities are reported in up to 70% of infants with congenital diaphragmatic hernia. [6] [7] [8] [9] Both brain maturational delays and evidence of brain injury have been reported on imaging. 8, 9 There continues to be some controversy about the correlation of neuroimaging abnormalities in CDH with neurologic outcome. In a small cohort of patients with CDH with prenatal and postnatal imaging, Tracy et al 9 identified an association between brain injury seen on postnatal CT/MR imaging in 4 infants and neurodevelopmental outcome at 1 year. There was no correlation between prenatal factors and neurodevelopmental outcome in this study. 9 In another study by Danzer et al, 10 postnatal brain MR imaging abnormalities were associated with lower cognitive scores, motor dysfunction, and language deficits. The impact of extracorporeal membrane oxygenation (ECMO) on neonates with CDH requiring ECMO is of clinical relevance. Studies suggest that neonates with CDH who require ECMO have a greater incidence of adverse neurodevelopmental sequelae, though it unclear whether the severity of the illness leading up to ECMO (hypercapnia, hypotension, and so forth) or the ECMO itself should be implicated. 6, 11 Which clinical factors in the neonatal intensive care unit play a role in brain injury in infants with CDH is yet to be determined.
In this study, we have developed a brain injury score to determine whether brain injury seen on predischarge MRI in infants with CDH is associated with diaphragmatic defect size and postnatal clinical factors in the NICU.
MATERIALS AND METHODS
After institutional review board approval, we retrospectively identified infants with CDH born between February 2009 and March 2014. We included infants with CDH with MR imaging of the brain before discharge as described in the flow chart (Fig 1) .
MR imaging was performed on these infants on 1.5T and 3T, and with a small-bore extremity 1.5T MR imaging scanner that was adapted for neonatal imaging in the neonatal intensive care unit.
12 MR imaging was performed without sedation after feeding and swaddling, except when excessive motion required light sedation. All studies included standard T1, T2, and susceptibility-and diffusion-weighted sequences. The MR images were independently reviewed by 2 pediatric neuroradiologists who were blinded to the clinical variables except for postmenstrual age at the time of MR imaging. Conflicts were resolved by consensus. The brain was evaluated for evidence of injury and then was scored on the basis of a system modified from previous work by Danzer et al 8, 10 and Tracy et al. 9 Table 1 lists the brain injury scoring guide. The total brain injury score was calculated in each infant. Examples of our scoring system are provided in Fig 2. The medical charts were reviewed to identify perinatal clinical factors and courses in the neonatal intensive care unit. The clinical variables extracted from the electronic medical record included type of diaphragmatic defect, gestational age, birth weight, Apgar scores at 1 and 5 minutes, the presence of congenital heart disease, the need for ECMO, days on a ventilator, the presence of blood stream infection, the need for and type of inotropic support, the need for oxygen at 28 days of life, any oral feeding at discharge, and gastrostomy tube placement before hospital discharge. The size of the diaphragmatic defect identified at surgery was classified according to the Congenital Diaphragmatic Hernia Study Group classification from A to D, A being a small defect and D indicating diaphragmatic agenesis. 5 Data were entered into REDCap (http://www.project-redcap. org/software.php), a secure on-line Web application. Statistical analysis was performed by using SAS software (Version 9.3; SAS Institute, Cary, North Carolina). Nonparametric tests and multivariable linear regression were performed by using clinical variables as potential predictors with the brain injury score as the continuous outcome.
RESULTS
There were 91 neonates with CDH admitted to the neonatal intensive care unit during the study; 28 died and 53 remained suitable for the study (Fig 1) . Demographic details are provided in Table 2 . Nine of the 53 neonates required ECMO during their treatment. In the 9 neonates who had ECMO, 2 had a type D defect and 7 had a type C defect.
MR imaging was performed at a mean corrected gestational age of 43.6 weeks (range, 37.0 -64.6 weeks). Fifty of the 53 infants were imaged at Ͻ48 weeks' corrected gestational age. MR imaging findings were considered abnormal (injury score of Ͼ0) in 32/53 (60%) infants. Enlarged extra-axial spaces were the most common abnormal finding on MR imaging, seen in 36% of infants.
Other abnormal findings on MR imaging included intraventricular hemorrhage in 23%, ventriculomegaly in 19%, white matter injury in 17%, cerebellar hemorrhage in 17%, parenchymal hemorrhage in 8%, cortical injury in 4%, and basal ganglia injury in 2% of infants. The distribution of brain injury scores in infants with CDH treated with ECMO and those without it is provided in Fig 3 . Ventriculomegaly, enlarged extra-axial spaces, parenchymal hemorrhage, and white matter injury were seen significantly more often in neonates who required ECMO compared with those without it (Table 3) . With the Spearman correlation for continuous predictor variables, there was a weak but significant correlation of the brain injury score with the number of ventilator days (correlation coefficient, 0.34; P ϭ .0014) and diaphragmatic defect severity (correlation coefficient, 0.30; P ϭ .027). There was no correlation between total injury score and gestational age in weeks, birth weight, Apgar scores, or bloodstream infection.
Univariate analysis of median differences in the brain injury scores and clinical variables in the neonatal intensive care unit showed that the use of ECMO (P ϭ .0001), use of inotropes (P ϭ .027), gastronomy tube placement before discharge (P ϭ .012), and not taking any oral feeding at discharge (P ϭ .024) were significantly associated with higher MR imaging brain injury scores. When we grouped the diaphragmatic defects into small (A and B) and large (C and D) defects, analysis with the Wilcoxon rank sum test showed that infants with type C or D diaphragmatic defects had significantly higher brain injury scores compared with infants with type A or B defects (P ϭ .011). Table 4 lists the clinical predictors of brain injury. There was a significant association among the use of ECMO, the presence of C or D diaphragmatic defect, and evidence of brain injury. Infants who were taking any feeding by mouth (as opposed to being entirely tube-fed) at the time of discharge had a greater chance of having normal brain MR imaging findings.
To better understand the etiology of ventriculomegaly and enlarged extra-axial spaces, we plotted the head circumference measurements of infants imaged before 50 weeks' corrected gestational age on a standard Fenton head circumference chart (Fig 4) . 13 Head circumference was measured within 5 days of the brain MR imaging in all cases. Infants with moderate or severe enlargement of the extra-axial spaces had normal or enlarged head size.
DISCUSSION
Management of CDH is complex, with various strategies used to improve outcomes. In general, our clinical management strategy for infants with CDH includes gentle ventilation, aggressive management of pulmonary hypertension with pulmonary vasodilators such as nitric oxide and epoprostenol, and surgical repair when pulmonary hypertension is subsystemic or has stabilized. ECMO is reserved for extremely sick infants who do not respond to standard medical management. Despite improved therapies, the early course in infants with CDH continues to be an extremely vulnerable period with great morbidity. In this article, we report the associations between clinical variables in the critical neonatal intensive care unit period and MR imaging evidence of brain injury in infants with CDH. MR imaging has been used as a tool to identify evidence of perinatal brain injury in vulnerable populations and to predict In our CDH population, enlarged extra-axial space was the most common abnormality, seen in 36% of the cases. This finding is similar to that in the cohort of Danzer et al, 10 in which enlarged extra-axial spaces were present in 40% of the patients with CDH. The enlarged extra-axial spaces were associated with lower cognitive scores in their study, and the presence of intracranial hemorrhage was associated with motor dysfunction. However, the effect of isolated enlarged extra-axial spaces on neurodevelopmental outcome, especially in neonates who have had ECMO, is somewhat controversial. 18 Enlargement of the extra-axial spaces is a common finding in neonates with ECMO, particularly in venovenous ECMO. [18] [19] [20] The obstruction of the internal jugular vein and/or the superior vena cava causes an elevation in intracranial venous pressure and poor resorption of CSF by the arachnoid villi. 21 In neonates with CDH, intrathoracic mass effect can cause relative obstruction of the central veins without ECMO. The large head circumferences in 2 of the 3 infants with ECMO with moderate-to-severe enlarged extra-axial spaces in our cohort support this hypothesis. While our prevalence of parenchymal hemorrhage is similar to that in the study of Danzer et al, 10 our cohort had a much higher incidence of intraventricular hemorrhage (23% compared with 2%). This may be due to use of susceptibility-weighted imaging in our population, which increases the sensitivity for the detection of blood products. In our study, infants on ECMO had a higher proportion of intraventricular and intraparenchymal hemorrhage compared with those without it. In 3 of these infants, minor intracranial hemorrhage was identified on screening head sonography during the course of ECMO, but this did not necessitate withdrawal of ECMO in these infants. We did not include small amounts of subdural or extra-axial hemorrhage in infants younger than 4 weeks of age as abnormal, given that this can be seen in healthy neonates following both vaginal and cesarean delivery. 22 Although previous reports describe subdural hemorrhage in infants with CDH, we did not see any abnormal subdural hemorrhage in our cohort. Cerebellar hemorrhage was seen in 17% of our population and has not been previously described in infants with CDH. Again, the use of SWI in our cohort may have increased the detection of this abnormality. The proposed etiology of cerebellar hemorrhage is impaired brain autoregulation, elevated venous pressure, and fetal distress. 23 We did not find a significant difference in cerebellar hemorrhage between infants with and without ECMO. Multiple intrauterine, perinatal, and surgical factors are described as associated with neonatal neurodevelopmental outcome, including the need for ECMO, the use of patch repair (a surrogate for large defect size), the presence of liver in the chest, the need for oxygen at 4 weeks of life, and hypotonicity. 24, 25 These factors would presumably also be associated with brain injury on imaging. Among the clinical variables assessed in our study, both large defect size and ECMO were predictors of the severity of brain injury identified on MR imaging. In our study, all the infants who needed ECMO had a large diaphragmatic defect; however, there was a substantial percentage (38%) of infants with large defects who did not require ECMO. The need for supplemental oxygen at 4 weeks of life was not associated with brain injury on imaging in our study. As expected, all our patients who required ECMO had evidence of intracranial abnormality, com- pared with 52% of the group without ECMO. In a previous study from 1999, Ahmad et al 11 showed that only 35% of patients with CDH and ECMO had evidence of CNS abnormality. This study used head sonography and CT to identify brain injury, and our numbers are likely higher due to the greater sensitivity of MR imaging in identifying subtle brain injury. In a study of infants with CDH from 1997, McGahren et al 6 showed a greater incidence of intracranial findings on head sonography and poor neurologic outcome in infants with CDH requiring ECMO. Rollins et al 26 performed a retrospective review of 50 neonates (24 with CDH) who underwent brain MR imaging after neonatal ECMO. MR imaging findings were abnormal in 62% of the infants, and MR imaging was more sensitive than head sonography at detecting brain abnormalities. Similar to findings in our study, abnormal carotid flow, ventriculomegaly, and increased extra-axial spaces were common. They found that neuroimaging was, in fact, not correlated with neurodevelopmental outcomes in the 20 patients who had 12-month follow-up. However, they only classified neuroimaging findings as "normal" or "abnormal" and did not attempt to categorize the severity of imaging abnormalities, which could have potentially impacted their results.
Venoarterial ECMO, which is used at our center for infants with CDH, requires cannulation of the right internal carotid artery. In addition to this vascular injury, systemic anticoagulation is required, greatly increasing the risk of cerebral hemorrhage. The initiation of ECMO launches a systemic inflammatory response, which also appears to affect the brain. 27 Use of ECMO has been found to have an effect on neurodevelopmental outcome. Gross motor skills are delayed in many children who received ECMO as neonates compared with healthy controls, though severe disability is uncommon. 28 Survivors of CDH who received ECMO appear to be more affected than those who required ECMO for other reasons, 29 and the cause of poor outcome in this cohort is unclear. Cognitive development in ECMO survivors also appears to be overall within the normal range, but lower than that in healthy controls. 28 Decreased performance is seen on neuropsychological tasks such as verbal reasoning and spatial abilities, 30 and children treated with ECMO are at risk for school difficulties despite normal overall intelligence. 31, 32 The increased brain injury seen in infants with CDH requiring ECMO in our study could provide a mechanism for some of these findings seen later in childhood. Our study has several limitations. Because this is a retrospective study, we could not control for imaging timing, which might affect the identification of brain injury. Predischarge MR imaging examinations assessed in this study were performed when the infants were clinically stable after surgical correction and ECMO if used. The exact cause of brain injury in this CDH population, especially in those requiring ECMO, is difficult to postulate. Neonates who require ECMO are usually sicker than those who do not require ECMO, and they may have had a period of clinical instability with hypotension, hypercarbia, and impaired cerebral autoregulation before the initiation of ECMO. It is therefore difficult to determine whether ECMO itself or the illness requiring ECMO contributes more to brain injury. Even if they do not require ECMO, infants with CDH are often initially very sick, with episodes of hypoxia, hypercarbia, hypotension, and acidosis. Use of inotropes can be associated with altered cerebral perfusion leading to brain injury. 33, 34 Major surgery with anesthesia would also contribute to brain injury in these neonates.
35,36
Only 53 of the 91 infants admitted to our neonatal intensive care unit during the study were included, mainly due to high mortality. Of the 28 infants who died, 21 had been on ECMO. Of the 63 survivors, 14 infants had ECMO and 9 were included in the study. The ECMO survivors that were included in our cohort may have represented the relatively less sick infants on ECMO who were clinically stable enough to be imaged. Because all our infants with ECMO had evidence of brain injury and the brain injury score was higher in infants with ECMO compared with those without it, it may be reasonably assumed that we imaged only the milder end of the spectrum and that infants with CDH needing ECMO would have a greater association with brain injury.
Imaging was performed on both 1.5T and 3T clinical scanners, which might affect the sensitivity of detection of brain abnormalities. We did not include sonography and CT reviews, because we believed that MR imaging was more sensitive in identifying brain injury. Neurodevelopmental tests on our group of infants with CDH are ongoing, and results are not included in this study. The clinical significance of the brain imaging abnormalities is therefore currently unknown. However, on the basis of available evi- dence of brain injury in infants with CDH, all infants with CDH now undergo brain MR imaging before discharge.
CONCLUSIONS
In this study, we demonstrated an association between perinatal clinical factors and brain imaging abnormalities in infants with congenital diaphragmatic hernia. The strongest association with brain abnormality is the use of ECMO, with the most common abnormality being enlarged extra-axial spaces. The presence of a large diaphragmatic defect was an intrinsic factor associated with abnormal brain imaging findings. Infants who were fed orally at the time of discharge were more likely to have normal neuroimaging findings.
